Katelyn Noronha

Katelyn Noronha is a highly skilled scientific professional with extensive experience in the fields of biochemistry and cancer research. Currently, as a Principal Scientist at AtlasXomics Inc., Katelyn also serves as a Scientific & Technical Liaison and Business Development Consultant. Prior to this role, Katelyn completed a PhD under Dr. Ranjit Bindra at Yale University, focusing on evaluating biomarkers for NAMPT inhibitor sensitivity in cancer. Katelyn's experience includes independent research at Northwestern University as an Undergraduate Research Assistant and an internship at Exact Sciences, where contributions were made to the product development of the Cologuard assay. Educationally, Katelyn earned both a Doctor of Philosophy in Biochemistry from Yale University and a Bachelor's Degree in Biochemistry from Northwestern University.